However, in patients with diabetic nephropathy, lncRNA Dlx6-os1 expression increases, resulting in GSK-3β upregulation, thus leading to increased expression of inflammatory factors and cell damage-associated factors, podocyte injury, and albuminuria. Here, DLX6 is linked to diabetic kidney disease.